Shannon M Parisotto Charles River Laboratories International, Inc. (CRL) insider trading activity

Shannon M Parisotto is CEVP, Disc & Safety Assessment of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 8,406 shares of CRL, which is worth approximately $1.39 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 1,727 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.41K

0% 3M change

0.07% 12M change

Total Value Held $1.39 Million

Shannon M Parisotto Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	BUY Grant, award, or other acquisition	-	1,727 Added 17.04%	8,406 Common Stock
May 29 2024	SELL Payment of exercise price or tax liability	$23,596 $214.51 p/Share	110 Reduced 1.62%	6,679 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$15,204 $217.21 p/Share	70 Reduced 1.02%	6,764 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$22,807 $217.21 p/Share	105 Reduced 1.51%	6,834 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$36,491 $217.21 p/Share	168 Reduced 2.36%	6,939 Common Stock
Feb 29 2024	SELL Open market or private sale	$960,583 $253.72 p/Share	3,786 Reduced 34.68%	7,132 Common Stock
Feb 15 2024	SELL Open market or private sale	$1,422,149 $241.78 p/Share	5,882 Reduced 69.38%	2,596 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	$850,948 $144.67 p/Share	5,882 Added 40.96%	8,478 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$122,255 $220.28 p/Share	555 Reduced 6.19%	8,412 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	2,115 Added 19.09%	8,967 Common Stock
May 29 2023	SELL Payment of exercise price or tax liability	$21,353 $194.12 p/Share	110 Reduced 1.49%	7,288 Common Stock
May 28 2023	SELL Payment of exercise price or tax liability	$13,782 $194.12 p/Share	71 Reduced 0.95%	7,398 Common Stock
May 27 2023	SELL Payment of exercise price or tax liability	$20,382 $194.12 p/Share	105 Reduced 1.39%	7,469 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	1,700 Added 18.33%	7,574 Common Stock
Feb 22 2023	SELL Payment of exercise price or tax liability	$33,129 $243.6 p/Share	136 Reduced 2.26%	5,874 Common Stock
Feb 16 2023	SELL Open market or private sale	$1,150,849 $252.49 p/Share	4,558 Reduced 43.13%	6,010 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	$498,371 $109.34 p/Share	4,558 Added 30.13%	10,568 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$320,037 $244.49 p/Share	1,309 Reduced 17.88%	6,010 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	4,820 Added 39.71%	7,319 Common Stock
Nov 15 2022	SELL Open market or private sale	$569,522 $249.9 p/Share	2,279 Reduced 47.7%	2,499 Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	$249,185 $109.34 p/Share	2,279 Added 32.29%	4,778 Common Stock

SMP

Shannon M Parisotto

CEVP, Disc & Safety Assessment

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account